Overview
Spherix’s coverage of emerging neurology indications focuses on evolving markets where a paradigm shift is expected in the coming years.
Services Available
Benchmarking new brand performance
Aduhelm (Biogen) in Alzheimer's Disease (US)
Prepping for the pipeline
Amyotrophic Lateral Sclerosis (US)
Alzheimer's Disease (US)
Narcolepsy (US)